A human monoclonal antibody specific to placental alkaline phosphatase, a marker of ovarian cancer

mAbs

Volumn 6, Issue 1, 2014, Pages 86-94

  Ravenni, Niccolo ^a   Weber, Marcel ^a   Neri, Dario ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

ALPP; Antibody phage technology; Ovarian carcinoma; Placental alkaline phosphatase; PLAP; Regan isoenzyme

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; HUMAN MONOCLONAL ANTIBODY; HUMAN MONOCLONAL ANTIBODY B10; HUMAN MONOCLONAL ANTIBODY D9; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY ISOLATION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; DISEASE MARKER; DISSOCIATION CONSTANT; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CANCER; QUANTITATIVE ANALYSIS; TISSUE PREPARATION; TUMOR CELL LINE; TUMOR LOCALIZATION;

ALKALINE PHOSPHATASE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; CELL LINE, TUMOR; FEMALE; GPI-LINKED PROTEINS; HETEROGRAFTS; HUMANS; IMMUNOASSAY; ISOENZYMES; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PREGNANCY PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892592542     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.27230     Document Type: Article

References (36)

1. Krall N, Scheuermann J, Neri D. Small targeted cytotoxics: current state and promises from DNAencoded chemical libraries. Angew Chem Int Ed Engl 2013; 52:1384-402; PMID:23296451; http://dx.doi. org/10.1002/anie.201204631
2. Senter PD. Potent antibody drug conjugates for cancer therapy. Curr Opin Chem Biol 2009; 13:235-44; PMID:19414278; http://dx.doi.org/10.1016/j. cbpa.2009.03.023
3. Chari RV. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 2008; 41:98-107; PMID:17705444; http://dx.doi. org/10.1021/ar700108g
4. Steiner M, Neri D. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends. Clin Cancer Res 2011; 17:6406-16; PMID:22003068; http://dx.doi.org/10.1158/1078-0432.CCR-11-0483
5. Borsi L, Balza E, Bestagno M, Castellani P, Carnemolla B, Biro A, Leprini A, Sepulveda J, Burrone O, Neri D, et al. Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 2002; 102:75-85; PMID:12353237; http://dx.doi. org/10.1002/ijc.10662
6. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol 2010; 177:1053-64; PMID:20651229; http://dx.doi.org/10.2353/ ajpath.2010.100105
7. Pietzner K, Jäger M, Schoberth A, Oskay-Özcelik G, Kuhberg M, Lindhofer H, Sehouli J. First patient treated with a re-challenge of catumaxomab in recurrent malignant ascites: a case report. Med Oncol 2012; 29:1391-6; PMID:21544631; http://dx.doi. org/10.1007/s12032-011-9961-5
8. Millán JL, Fishman WH. Biology of human alkaline phosphatases with special reference to cancer. Crit Rev Clin Lab Sci 1995; 32:1-39; PMID:7748466; http://dx.doi.org/10.3109/10408369509084680
9. Klein EA. Tumor markers in testis cancer. Urol Clin North Am 1993; 20:67-73; PMID:7679533 (Pubitemid 23065505)
10. Koshida K, Nishino A, Yamamoto H, Uchibayashi T, Naito K, Hisazumi H, Hirano K, Hayashi Y, Wahren B, Andersson L. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors. J Urol 1991; 146:57-60; PMID:1711586
11. Lange PH, Millan JL, Stigbrand T, Vessella RL, Ruoslahti E, Fishman WH. Placental alkaline phosphatase as a tumor marker for seminoma. Cancer Res 1982; 42:3244-7; PMID:7093962 (Pubitemid 12041086)
12. Otto VI, Schär BK, Sulser T, Hänseler E. Specific determination of germ cell alkaline phosphatase for early diagnosis and monitoring of seminoma: performance and limitations of different analytical techniques. Clin Chim Acta 1998; 273:131-47; PMID:9657344; http://dx.doi.org/10.1016/ S0009-8981(98)00031-X (Pubitemid 28279768)
13. Fishman WH. Clinical and biological significance of an isozyme tumor marker-PLAP. Clin Biochem 1987; 20:387-92; PMID:3325192; http://dx.doi. org/10.1016/0009-9120(87)90003-8 (Pubitemid 18035407)
14. Hofmann MC, Millán JL. Developmental expression of alkaline phosphatase genes; reexpression in germ cell tumours and in vitro immortalized germ cells. Eur Urol 1993; 23:38-44, discussion 45; PMID:8386657
15. Millán JL. Alkaline phosphatase as a reporter of cancerous transformation. Clin Chim Acta 1992; 209:123-9; PMID:1395034; http://dx.doi. org/10.1016/0009-8981(92)90343-O
16. Schär BK, Otto VI, Hänseler E. Simultaneous detection of all four alkaline phosphatase isoenzymes in human germ cell tumors using reverse transcription-PCR. Cancer Res 1997; 57:3841-6; PMID:9288797 (Pubitemid 27381233)
17. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004; 101:6062-7; PMID:15075390; http:// dx.doi.org/10.1073/pnas.0400782101 (Pubitemid 38520528)
18. Snook DE, Rowlinson-Busza G, Sharma HL, Epenetos AA. Preparation and in vivo study of 124I-labelled monoclonal antibody H17E2 in a human tumour xenograft model. A prelude to positron emission tomography (PET). Br J Cancer Suppl 1990; 10:89-91; PMID:2383487 (Pubitemid 20226492)
19. Kellermann SA, Green LL. Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics. Curr Opin Biotechnol 2002; 13:593-7; PMID:12482519; http://dx.doi. org/10.1016/S0958-1669(02)00354-3 (Pubitemid 35448061)
20. Lonberg N. Human antibodies from transgenic animals. Nat Biotechnol 2005; 23:1117-25; PMID:16151405; http://dx.doi.org/10.1038/nbt1135 (Pubitemid 41486393)
21. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol 1994; 12:433-55; PMID:8011287; http://dx.doi.org/10.1146/annurev. iy.12.040194.002245
22. Silacci M, Brack S, Schirru G, Mårlind J, Ettorre A, Merlo A, Viti F, Neri D. Design, construction, and characterization of a large synthetic human antibody phage display library. Proteomics 2005; 5:2340-50; PMID:15880779; http://dx.doi.org/10.1002/ pmic.200401273 (Pubitemid 40835403)
23. Silacci M, Brack SS, Späth N, Buck A, Hillinger S, Arni S, Weder W, Zardi L, Neri D. Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng Des Sel 2006; 19:471-8; PMID:16928692; http:// dx.doi.org/10.1093/protein/gzl033 (Pubitemid 44408907)
24. Villa A, Lovato V, Bujak E, Wulhfard S, Pasche N, Neri D. A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectin. MAbs 2011; 3:264-72; PMID:21487243; http://dx.doi.org/10.4161/ mabs.3.3.15616
25. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotný J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R, et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A 1988; 85:5879-83; PMID:3045807; http://dx.doi. org/10.1073/pnas.85.16.5879
26. Tomlinson IM, Walter G, Jones PT, Dear PH, Sonnhammer EL, Winter G. The imprint of somatic hypermutation on the repertoire of human germline V genes. J Mol Biol 1996; 256:813-7; PMID:8601832; http://dx.doi.org/10.1006/jmbi.1996.0127 (Pubitemid 26108820)
27. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 1994; 13:3245-60; PMID:8045255 (Pubitemid 24226939)
28. Hoogenboom HR, Marks JD, Griffiths AD, Winter G. Building antibodies from their genes. Immunol Rev 1992; 130:41-68; PMID:1286871; http:// dx.doi.org/10.1111/j.1600-065X.1992.tb01520.x (Pubitemid 23014841)
29. Pfaffen S, Hemmerle T, Weber M, Neri D. Isolation and characterization of human monoclonal antibodies specific to MMP-1A, MMP-2 and MMP-3. Exp Cell Res 2010; 316:836-47; PMID:19913533; http://dx.doi.org/10.1016/j.yexcr.2009.11.004
30. Frey K, Zivanovic A, Schwager K, Neri D. Antibodybased targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integr Biol (Camb) 2011; 3:468-78; PMID:21225052; http:// dx.doi.org/10.1039/c0ib00099j
31. List T, Neri D. Biodistribution studies with tumortargeting bispecific antibodies reveal selective accumulation at the tumor site. MAbs 2012; 4:775-83; PMID:23032949; http://dx.doi.org/10.4161/ mabs.22271
32. Pasche N, Woytschak J, Wulhfard S, Villa A, Frey K, Neri D. Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7. J Biotechnol 2011; 154:84-92; PMID:21527292; http://dx.doi.org/10.1016/j.jbiotec. 2011.04.003
33. Viti F, Nilsson F, Demartis S, Huber A, Neri D. Design and use of phage display libraries for the selection of antibodies and enzymes. Methods Enzymol 2000; 326:480-505; PMID:11036659; http://dx.doi.org/10.1016/S0076-6879(00)26071- 0
34. Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak JN, Rösli C, Borsi L, Neri D. A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo. Int J Cancer 2008; 122:2405-13; PMID:18271006; http://dx.doi.org/10.1002/ijc.23408 (Pubitemid 351590471)
35. Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res 1991; 19:4133-7; PMID:1908075; http://dx.doi.org/10.1093/ nar/19.15.4133 (Pubitemid 21912784)
36. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 1991; 222:581-97; PMID:1748994; http://dx.doi. org/10.1016/0022-2836(91)90498-U